On 10 December 2025, Amplex AB (“Amplex” or the “Bidder”) announced a public offer to the shareholders and warrant holders of ADDvise Group AB (publ) (“ADDvise” or the “Company”) to transfer all shares and warrants in the Company to Amplex (the “Offer”). Today, Amplex announced an increase of the price in the Offer to SEK … Read more
Amplex AB (“Amplex”) has today announced a public offer to the shareholders and warrant holders of ADDvise Group AB (publ) (“ADDvise”) to transfer all shares and warrants in ADDvise to Amplex at a price of SEK 1.65 in cash for each class A and class B share and SEK 0.49 in cash for each warrant … Read more
ADDvise Group’s subsidiary MRC Systems has received an order from IPS. IPS are a global engineering firm that delivers complex projects within life science. The order is worth approximately USD 2.3 million. The order involves design, paneling, and installation of a cleanroom and associated accessories for a new pharmaceutical manufacturing facility located in the United … Read more
In accordance with the resolution at the Annual General Meeting 2022 of ADDvise Group, the nomination committee for the Annual General Meeting 2026 shall comprise of representatives of the three largest shareholders by votes, according to the shareholders’ register as of 30 June 2025 maintained by Euroclear Sweden, and of the chairman of the board … Read more
Strengthened profitability and cash flow despite a quarter with macro headwinds. In the third quarter, organic sales decreased by 4.8% in constant currency, but the year-to-date growth remains positive. The work on operational efficiency is having an effect and EBITA increased by SEK 1.0 million while the EBITA margin amounted to 15.5% (13.7%). Cash flow … Read more
ADDvise Group publishes its interim report January 1 – September 30, 2025 on Thursday, October 23, 2025 at 7.45 am (CET). Media, investors and analysts are invited to attend a webcast and teleconference on the same day at 14:00 (CET). CEO, Staffan Torstensson, and CFO, Johan Irwe, will present the report. WebcastIf you wish to … Read more
In the second quarter of 2025, organic sales adjusted for currency effects increased, driven by steady demand for laboratory equipment and rental of equipment for clinical studies. Operating cash flow improved in the quarter, and EBITA was in line with last year with a stronger margin. Through the new capital structure, ADDvise’s annual interest expenses … Read more
On 28 May 2025, ADDvise Group AB (publ) (“ADDvise”) successfully issued senior unsecured bonds in an amount of SEK 800 million, under a total framework of SEK 1,600 million (the “Bonds”). Pursuant to the terms and conditions for the Bonds, ADDvise has undertaken to apply for admission to trading of the Bonds on the corporate … Read more
ADDvise Group publishes its interim report April 1 – June 30, 2025 on Thursday, July 17, 2025 at 7.45 am (CET). Media, investors and analysts are invited to attend a webcast and teleconference on the same day at 14:00 (CET). CEO, Staffan Torstensson, and CFO, Johan Irwe, will present the report. Webcast If you … Read more
ADDvise Group AB (publ) (“ADDvise” or the “Company”) announced on 14 May 2025 that ADDvise intends to redeem the Company’s outstanding senior secured bonds with ISIN SE0020180271 and ISIN NO0013180786 (the “Early Redemption”). The Early Redemption was conditional upon the entering into of the new secured facilities agreement of the equivalence of SEK 450 million … Read more